Abstract
This review presents a survey of acyl glucuronides (AGs) from the perspective of a synthetic medicinal chemist. After a brief introduction to the biogenesis of AGs and current attitudes of the pharmaceutical industry towards them, the importance of the availability of pure synthetic AGs as probe molecules is stressed. Current synthetic methods including the selective acylation method and enzymatic procedures are discussed with actual drug examples. The major reaction pathways of AGs, acyl migration and direct acyl transfer, are then examined with consideration of both in vitro and in vivo situations. Both the aglycone and the carbohydrate residue are shown to be important in determining the reactivity of AGs, especially the α-substitution in aryl acetates and propionates and aryl substitution in benzoates. The significance of these effects for important drugs such as the NSAIDs diclofenac and ibuprofen is noted. Appropriate models of the reactivity of AGs with proteins are presented, from short model peptides to body proteins, and examples where AGs clearly interact with protein in vivo (e. g. mycophenolic acid) are presented. Recent results with AGs in plasma, where half-lives differ significantly from their values in aqueous buffer, show the importance of considering the external medium especially when other hydrolytic enzymes are present. Finally, the importance of considering the reactivity of acyl thioesters-which may be formed directly or via AGs as intermediates- is also stressed. This pathway may lead to different protein reactivity than shown for AGs themselves, including interference with the glutathione pathway as shown for NSAID-like carboxylic acids.
Keywords: Drug metabolism, drug toxicity, glucuronides, acyl migration, carbohydrate synthesis, protein reactivity, aglycone, NSAID, mycophenolic acid, acidolysis
Current Drug Metabolism
Title: Chemistry and Reactivity of Acyl Glucuronides
Volume: 12 Issue: 3
Author(s): Andrew V. Stachulski
Affiliation:
Keywords: Drug metabolism, drug toxicity, glucuronides, acyl migration, carbohydrate synthesis, protein reactivity, aglycone, NSAID, mycophenolic acid, acidolysis
Abstract: This review presents a survey of acyl glucuronides (AGs) from the perspective of a synthetic medicinal chemist. After a brief introduction to the biogenesis of AGs and current attitudes of the pharmaceutical industry towards them, the importance of the availability of pure synthetic AGs as probe molecules is stressed. Current synthetic methods including the selective acylation method and enzymatic procedures are discussed with actual drug examples. The major reaction pathways of AGs, acyl migration and direct acyl transfer, are then examined with consideration of both in vitro and in vivo situations. Both the aglycone and the carbohydrate residue are shown to be important in determining the reactivity of AGs, especially the α-substitution in aryl acetates and propionates and aryl substitution in benzoates. The significance of these effects for important drugs such as the NSAIDs diclofenac and ibuprofen is noted. Appropriate models of the reactivity of AGs with proteins are presented, from short model peptides to body proteins, and examples where AGs clearly interact with protein in vivo (e. g. mycophenolic acid) are presented. Recent results with AGs in plasma, where half-lives differ significantly from their values in aqueous buffer, show the importance of considering the external medium especially when other hydrolytic enzymes are present. Finally, the importance of considering the reactivity of acyl thioesters-which may be formed directly or via AGs as intermediates- is also stressed. This pathway may lead to different protein reactivity than shown for AGs themselves, including interference with the glutathione pathway as shown for NSAID-like carboxylic acids.
Export Options
About this article
Cite this article as:
V. Stachulski Andrew, Chemistry and Reactivity of Acyl Glucuronides, Current Drug Metabolism 2011; 12 (3) . https://dx.doi.org/10.2174/138920011795101822
DOI https://dx.doi.org/10.2174/138920011795101822 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Impact of brain tissue binding and plasma protein binding of drugs in DMPK
The impression of brain tissue binding (BTB) or plasma protein binding (PPB) in Drug Metabolism and Pharmacokinetics is critical to understanding the distribution, efficacy, and potential toxicity of drugs that target the central nervous system (CNS). BTB and high PPB influence the distribution of drugs in the body and their ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Metabolism-Mediated Xenobiotic Toxicity
Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and ...read more
Safety evaluation of vaccine combination
Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without ...read more

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phytotherapy and NAFLD - from Goals and Challenges to Clinical Practice
Reviews on Recent Clinical Trials Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
Recent Patents on Anti-Cancer Drug Discovery Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy Statin-induced Vascular Smooth Muscle Cell Apoptosis: A Possible Role in the Prevention of Restenosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiac Remodeling Induced by Smoking: Concepts, Relevance, and Potential Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications
Current Rheumatology Reviews Stem Cell Niche in Tissue Homeostasis, Aging and Cancer
Current Medicinal Chemistry Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Strategies for COVID-19 - A Review of the Most Promising Repurposed Antiviral Drugs
Infectious Disorders - Drug Targets In Silico Screening for Potent Inhibitors against the NS3/4A Protease of Hepatitis C Virus
Current Pharmaceutical Design Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?
Current Drug Targets Quality of Life of Healthcare Workers Suffering from Occupational Contact Dermatitis
Recent Advances in Inflammation & Allergy Drug Discovery Delivery of Bioactive Peptides and Proteins Across Oral (Buccal) Mucosa
Current Pharmaceutical Biotechnology Biomarkers Insights in Psoriasis - Regulatory Cytokines
Current Biomarkers (Discontinued) Multiple Roles of Transient Receptor Potential (TRP) Channels in Inflammatory Conditions and Current Status of Drug Development
Current Topics in Medicinal Chemistry Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells
Protein & Peptide Letters Biomarkers in Unstable Carotid Plaque: Physiopathology and Prediction
Cardiovascular & Hematological Agents in Medicinal Chemistry In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued)